Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$25K Sell
700
-100
-13% -$3.72K ﹤0.01% 7722
2014
Q2
$31K Sell
800
-4,300
-84% -$161K ﹤0.01% 7520
2014
Q1
$186K Buy
5,100
+5,000
+5,000% +$182K ﹤0.01% 5272
2013
Q4
$3K Sell
100
-600
-86% -$19.3K ﹤0.01% 9889
2013
Q3
$20K Sell
700
-2,800
-80% -$74.6K ﹤0.01% 8066
2013
Q2
$94K Buy
+3,500
New +$96.6K ﹤0.01% 5988

Other funds holding XYL

UBS's XYL Position: Q3 2014 in Review

UBS increased its Xylem (XYL) stake by 1.8% in Q3 2014, buying an estimated $202K and bringing the position to 304,453 shares worth $10.8M. The position accounts for 0.01% of the portfolio, ranked #1394.

UBS first reported a position in XYL in Q2 2013 and has held it in 6 quarters since. The position peaked at $11.7M in Q2 2014. 439 funds tracked by Wall St. Rank hold XYL as of Q3 2014.

  • UBS held 304,453 shares of Xylem worth $10.8M as of Q3 2014.
  • UBS bought 5,438 Xylem shares in Q3 2014, an estimated $202K.
  • Xylem made up 0.01% of UBS's portfolio in Q3 2014, its #1394 holding.
  • UBS first reported a position in Xylem in Q2 2013 and has held it in 6 quarters since.
  • UBS's Xylem position peaked at $11.7M in Q2 2014.
  • 439 funds tracked by Wall St. Rank held Xylem as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.